Table 2.
Proportion of patients belonging in each clinical group with overlaps
| (%) | Commercial | Medicare | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ASCVD | HF | CKD | Hypo | Obesity | ASCVD | HF | CKD | Hypo | Obesity | |
| Overall membership | 23.3 | 5.2 | 15.8 | 0.6 | 59.7 | 60.9 | 19.8 | 39.6 | 2 | 55.5 |
| Clinical subgroups | ||||||||||
| ASCVD | 100 | 22.4 | 25.2 | 1.2 | 68.5 | 100 | 32.5 | 46.6 | 2.7 | 60.6 |
| No ASCVD | 0 | 0 | 13 | 0.4 | 57 | 0 | 0 | 28.7 | 0.9 | 47.5 |
| HF | 100 | 100 | 38.7 | 1.9 | 75.4 | 100 | 100 | 61.1 | 4.5 | 67.6 |
| No HF | 19 | 0 | 14.5 | 0.5 | 58.8 | 51.2 | 0 | 34.3 | 1.4 | 52.5 |
| CKD | 37.1 | 12.7 | 100 | 1.5 | 66.1 | 71.6 | 30.5 | 100 | 3.4 | 61.7 |
| No CKD | 20.7 | 3.8 | 0 | 0.4 | 58.5 | 53.8 | 12.7 | 0 | 1.1 | 51.4 |
| Hypo | 47.6 | 16.7 | 39.2 | 100 | 66.7 | 82.7 | 44.5 | 67.4 | 100 | 64 |
| No hypo | 23.1 | 5.1 | 15.7 | 0 | 59.7 | 60.4 | 19.3 | 39.1 | 0 | 55.3 |
| Obesity | 26.7 | 6.6 | 17.5 | 0.7 | 100 | 66.5 | 24.1 | 44.1 | 2.3 | 100 |
| No obesity | 18.2 | 3.2 | 13.3 | 0.5 | 0 | 53.9 | 14.4 | 34.1 | 1.6 | 0 |
ASCVD atherosclerotic cardiovascular disease; CKD chronic kidney disease; HF heart failure; Hypo hypoglycemia
Data in each cell represent the percentage of overlap between corresponding column and row